메뉴 건너뛰기




Volumn 119, Issue 12, 2009, Pages 838-841

A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase

Author keywords

Chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA; Imatinib

Indexed keywords

BCR ABL PROTEIN; DASATINIB; HYDROXYUREA; IMATINIB; JANUS KINASE 2; MERCAPTOPURINE; NILOTINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

EID: 75649147065     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.861     Document Type: Article
Times cited : (1)

References (8)
  • 1
    • 85080598305 scopus 로고    scopus 로고
    • Hellmann A, Prejzner W. [Hypereosinophilic syndrome and chronic eosinophilic leukemia]. In: Szczeklik A, ed. Internal Diseases. 2. Kraków: Medycyna Praktyczna; 2005: 1500-1503. Polish.
    • Hellmann A, Prejzner W. [Hypereosinophilic syndrome and chronic eosinophilic leukemia]. In: Szczeklik A, ed. Internal Diseases. Vol. 2. Kraków: Medycyna Praktyczna; 2005: 1500-1503. Polish.
  • 2
    • 34249732053 scopus 로고    scopus 로고
    • Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
    • Jovanovic JV, Score J, Waghom K, et al. Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood. 2007; 109: 4635-4640.
    • (2007) Blood , vol.109 , pp. 4635-4640
    • Jovanovic, J.V.1    Score, J.2    Waghom, K.3
  • 3
    • 16344392969 scopus 로고    scopus 로고
    • Targeted imatinib therapy in a patient with chronic eosinophilic leukemia]
    • Polish
    • Prejzner W, Szatkowski D, Wasa̧g B, et al. [Targeted imatinib therapy in a patient with chronic eosinophilic leukemia]. Wspólczesna onkologia. 2005; 9: 7-10. Polish.
    • (2005) Wspólczesna onkologia , vol.9 , pp. 7-10
    • Prejzner, W.1    Szatkowski, D.2    Wasa̧g, B.3
  • 4
    • 40949147830 scopus 로고    scopus 로고
    • A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1l1-PDGFRA-expressing patients
    • Helbig G, Stella-Hołowiecka B, Majewski M, et al. A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1l1-PDGFRA-expressing patients. Br J Haematol. 2008; 141: 200-204.
    • (2008) Br J Haematol , vol.141 , pp. 200-204
    • Helbig, G.1    Stella-Hołowiecka, B.2    Majewski, M.3
  • 5
    • 0344987881 scopus 로고    scopus 로고
    • A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    • Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003; 348: 1201-1214.
    • (2003) N Engl J Med , vol.348 , pp. 1201-1214
    • Cools, J.1    DeAngelo, D.J.2    Gotlib, J.3
  • 6
    • 3042678647 scopus 로고    scopus 로고
    • Clinical and molecular features of FIP1l1-PDGFRA (+) chronic eosinophilic leukemias
    • Vandenberghe P, Wlodarska I, Michaux L, et al. Clinical and molecular features of FIP1l1-PDGFRA (+) chronic eosinophilic leukemias. Leukemia. 2004; 18: 734-742.
    • (2004) Leukemia , vol.18 , pp. 734-742
    • Vandenberghe, P.1    Wlodarska, I.2    Michaux, L.3
  • 7
    • 8644263305 scopus 로고    scopus 로고
    • FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
    • Pardanani A, Brockman SR, Paternoster SF, et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood. 2004; 104: 3038-3045.
    • (2004) Blood , vol.104 , pp. 3038-3045
    • Pardanani, A.1    Brockman, S.R.2    Paternoster, S.F.3
  • 8
    • 1842474941 scopus 로고    scopus 로고
    • The FIP1l1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification, and management
    • Gotlib J, Cools J, Malone JM. et al. The FIP1l1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management Blood. 2004; 103: 2879-2891.
    • (2004) Blood , vol.103 , pp. 2879-2891
    • Gotlib, J.1    Cools, J.2    Malone, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.